FBTCX Mutual Fund

FBTCX Mutual Fund

NAV$37.60
See how much of FBTCX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 50 of 126 holdings · as of Aug 31, 2026
FBTCX holdings, by weight
#TickerNameWeightCumulativeMkt valueSectorIndustry
1
ABBV
AbbVie Inc.Health Care · Pharmaceuticals
13.83%		13.8%$335.78MHealth CarePharmaceuticals
2
GILD
Gilead SciencesHealth Care · Pharmaceuticals
6.02%		19.9%$146.24MHealth CarePharmaceuticals
Sector and industry · Pro
3
ALNY
Alnylam Pharmaceuticals Inc.
3.84%		23.7%$93.19M
4
INSM
Insmed Inc
3.41%		27.1%$82.87M
5
AMLX
Amylyx Pharmaceuticals Inc
3.38%		30.5%$82.12M
6—Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
3.28%		33.8%$79.64M
7
DNTH
Dianthus Therapeutics Inc
3.18%		36.9%$77.10M
8
SYRE
Spyre Therapeutics Inc
3.15%		40.1%$76.59M
9
MRNA
Moderna Inc
3.12%		43.2%$75.85M
10
RVMD
Revolution Medicines Inc
2.98%		46.2%$72.40M
11—Ascendis Pharma A/S
2.92%		49.1%$70.82M
12
ORKA
Oruka Therapeutics Inc Orka
2.81%		51.9%$68.30M
13
COGT
Cogent Biosciences Inc
2.65%		54.6%$64.22M
14
BIIB
Biogen Inc.
2.62%		57.2%$63.72M
15
AMGN
Amgen Inc.
2.39%		59.6%$58.08M
16
MBX
Mbx Biosciences Inc
2.08%		61.7%$50.36M
17
PCVX
Vaxcyte Inc
2.01%		63.7%$48.68M
18
NTRA
Natera Inc
1.96%		65.6%$47.49M
19
VRDN
Viridian Therapeutics Inc
1.70%		67.3%$41.28M
20
VRTX
Vertex Pharmaceuticals Inc
1.43%		68.8%$34.79M
21
FTBFX
Fidelity Cash Central Fund
1.42%		70.2%$34.55M
22
RLAY
Relay Therapeutics Inc
1.40%		71.6%$34.02M
23—Kiniksa Pharmaceuticals Inte
1.35%		72.9%$32.84M
24
ELVN
Enliven Therapeutics Inc
1.20%		74.1%$29.02M
25
KYMR
Kymera Therapeutics Inccommon Stock
1.13%		75.3%$27.53M
26—Roivant Sciences Ltd. Common Shares
1.11%		76.4%$26.90M
27
CLDX
Celldex Therapeutics Inc
1.06%		77.4%$25.80M
28—Structure Therapeutics Inc Adr
1.00%		78.4%$24.24M
29
PRAX
Praxis Precision Medicines Inc
0.92%		79.3%$22.21M
30
ALMS
Alumis Inc
0.85%		80.2%$20.64M
31—Xenon Pharmaceuticals Inc
0.85%		81.0%$20.61M
32
REGN
Regeneron Pharmaceuticals, Inc.
0.74%		81.8%$17.98M
33
NXTC
Nextcure Inc
0.73%		82.5%$17.79M
34
ZBIO
Zenas Biopharma Inc
0.66%		83.2%$15.89M
35
JBIO
Jade Biosciences Inc
0.65%		83.8%$15.84M
36
VKTX
Viking Therapeutics Inc
0.61%		84.4%$14.76M
37
ELYM
Eliem Therapeutics Inc.
0.56%		85.0%$13.68M
38
TARS
Tarsus Pharmaceuticals Inc
0.55%		85.5%$13.36M
39
DYN
Dyne Therapeutics Inc
0.51%		86.1%$12.26M
40
RCUS
Arcus Biosciences Inc
0.50%		86.6%$12.24M
41
CGON
Cg Oncology Inc
0.49%		87.0%$11.85M
42—Definium Therapeutics, Inc. Common Shares
0.49%		87.5%$11.82M
43
PBLS
Parabilis Medicines Inc
0.49%		88.0%$11.84M
44—Newamsterdam Pharma Nv
0.47%		88.5%$11.35M
45
MLYS
Mineralys Therapeutics Inc
0.45%		88.9%$10.80M
46
ACRS
Aclaris Therapeutics Inc
0.44%		89.4%$10.77M
47
STOK
Stoke Therapeuti
0.41%		89.8%$9.91M
48
TRAX
First Tracks Biotherapeutics, Inc.
0.38%		90.2%$9.11M
49
TYRA
Tyra Biosciences Inc
0.36%		90.5%$8.87M
50
DMRA
Damora Therapeutics Inc
0.35%		90.9%$8.40M
More holdings · Pro
Not reported for this fund: shares, share changes.
FundXLS Pro
See the other 76 holdings of FBTCX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

FBTCX Mutual Fund All Holdings

FBTCX holdings total 131 positions. The top 10 holdings account for 46.2% of the fund, led by Abbvie Inc. at 13.8%, Gilead Sciences at 6.0%, Alnylam Pharmaceuticals Inc. at 3.8%.

FBTCX portfolio concentration is moderate, with the top 10 representing 46.2% of total assets. The largest sector exposure is Health Care at 90.4%.

FBTCX sectors provide a detailed breakdown. FBTCX overlap shows how holdings compare to other funds in your portfolio.